Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes

Signe Holm Nielsen1, Alan J Mouton2, Kristine Y DeLeon-Pennell3

  • 1Fibrosis Biology and Biomarkers, Nordic Bioscience, Herlev, Denmark; Disease Systems Immunology, Technical University of Denmark, Kgs. Lyngby, Denmark.

Insights

Myocardial infarction (MI) triggers left ventricle (LV) scar formation. This review explores extracellular matrix (ECM) remodeling and biomarkers for predicting MI outcomes.

Area of Science:

  • Cardiovascular research
  • Cardiac remodeling
  • Biomarker discovery

Background:

  • Cardiovascular Disease (CVD) is a leading cause of death globally.
  • Myocardial infarction (MI) significantly contributes to CVD morbidity and mortality.
  • Post-MI healing involves extracellular matrix (ECM) scar formation in the left ventricle (LV).

Purpose of the Study:

  • To review left ventricle (LV) extracellular matrix (ECM) remodeling after myocardial infarction (MI).
  • To identify and discuss ECM biomarkers for predicting MI outcomes.
  • To differentiate between beneficial scar formation and detrimental fibrosis post-MI.

Main Methods:

  • Literature review focusing on post-MI cardiac fibrosis and ECM remodeling.
  • Analysis of existing research on extracellular matrix (ECM) components and their roles.
  • Identification of potential ECM biomarkers associated with MI prognosis.

Main Results:

  • Cardiac fibrosis post-MI is complex, involving both structural scarring and detrimental stiffening.
  • Distinguishing between adaptive and maladaptive ECM accumulation is crucial.
  • Specific ECM biomarkers show potential for predicting adverse LV remodeling and heart failure progression.

Conclusions:

  • Understanding LV ECM remodeling post-MI is key to improving patient outcomes.
  • ECM biomarkers could offer valuable prognostic information for MI patients.
  • Further research into ECM dynamics and biomarker validation is warranted.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
934
The Extracellular Matrix01:42

The Extracellular Matrix

Overview
89.7K
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
12.5K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
456